1. Home
  2. APVO vs SOPA Comparison

APVO vs SOPA Comparison

Compare APVO & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APVO
  • SOPA
  • Stock Information
  • Founded
  • APVO 2016
  • SOPA 2018
  • Country
  • APVO United States
  • SOPA Singapore
  • Employees
  • APVO N/A
  • SOPA N/A
  • Industry
  • APVO Biotechnology: Pharmaceutical Preparations
  • SOPA EDP Services
  • Sector
  • APVO Health Care
  • SOPA Technology
  • Exchange
  • APVO Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • APVO 5.4M
  • SOPA 6.3M
  • IPO Year
  • APVO N/A
  • SOPA 2021
  • Fundamental
  • Price
  • APVO $1.38
  • SOPA $0.82
  • Analyst Decision
  • APVO Strong Buy
  • SOPA Buy
  • Analyst Count
  • APVO 1
  • SOPA 2
  • Target Price
  • APVO $296.00
  • SOPA $16.00
  • AVG Volume (30 Days)
  • APVO 1.2M
  • SOPA 77.5K
  • Earning Date
  • APVO 05-07-2025
  • SOPA 05-14-2025
  • Dividend Yield
  • APVO N/A
  • SOPA N/A
  • EPS Growth
  • APVO N/A
  • SOPA N/A
  • EPS
  • APVO N/A
  • SOPA N/A
  • Revenue
  • APVO N/A
  • SOPA $6,906,240.00
  • Revenue This Year
  • APVO N/A
  • SOPA $7.97
  • Revenue Next Year
  • APVO N/A
  • SOPA $15.61
  • P/E Ratio
  • APVO N/A
  • SOPA N/A
  • Revenue Growth
  • APVO N/A
  • SOPA N/A
  • 52 Week Low
  • APVO $0.94
  • SOPA $0.73
  • 52 Week High
  • APVO $180.19
  • SOPA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • APVO 31.11
  • SOPA 34.46
  • Support Level
  • APVO $0.94
  • SOPA $1.10
  • Resistance Level
  • APVO $2.64
  • SOPA $1.18
  • Average True Range (ATR)
  • APVO 0.45
  • SOPA 0.08
  • MACD
  • APVO -0.07
  • SOPA -0.01
  • Stochastic Oscillator
  • APVO 16.42
  • SOPA 3.61

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with visionary entrepreneurs, the company meets the growing demand for better services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food and grocery deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Merchant Point of Sale (merchant POS). The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: